— Know what they know.
Not Investment Advice
Also trades as: MSB.AX (ASX) · $vol 4M · MESO (NASDAQ) · $vol 3M

MEOBF Earnings

Mesoblast Limited
1W: +0.0% 1M: -30.5% 3M: -22.4% YTD: -30.5% 1Y: -20.0% 3Y: +131.6% 5Y: -29.8%
$1.32
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 43 · $1.7B mcap · 850M float · 0.0016% daily turnover · Short 66% of daily vol
Credit Risk of going bust: lower than 59% of companies Debt: 6.9% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.01 (down 99.1%), Mesoblast Limited would be worth roughly what it owes.
Total debt $127.3M against a stock market value of $1.71B.
Distance to default 6.09 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $64.9M (short-term plus half of long-term), stock volatility 54.7%; Altman Z'' -1.05. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Last Earnings 2026-08-26
EPS
$-0.01
▼ Miss -22.6%
Revenue
$69M
▲ Beat +25.7%
Next Earnings Qtr ending 2026-12-30 · date TBD
EPS Estimate
$-0.04
Range: $-0.04 - $-0.04
Revenue Estimate
$2M
1 analysts

Estimate vs Actual

Earnings Surprise History

8/20
EPS Beats
1/20
Revenue Beats
40%
EPS Beat Rate
5%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-21 quarter 2031-09-30 $0.02 $0.02 — $169,086,826 $166,086,826
2026-10-21 quarter 2030-12-30 $-0.01 $-0.01 — $106,592,959 $102,412,959
2026-10-21 annual 2029-06-30 $0.10 $0.10 — $735,490,130 $735,494,964
2026-10-21 annual 2028-06-30 $0.01 $0.01 — $381,842,823 $376,817,723
2026-10-21 annual 2027-06-30 $-0.02 $-0.02 — $208,126,014 $201,301,399
2026-10-21 quarter 2030-09-30 $-0.02 $-0.01 ▲ 0.01 $86,234,600 $79,314,600
2026-10-21 quarter 2031-03-30 $-0.01 $-0.01 — $99,177,463 $96,744,129
2026-10-20 annual 2029-06-30 $0.11 $0.10 ▼ 0.01 $736,411,630 $735,490,130
2026-10-20 annual 2028-06-30 $0.01 $0.01 — $382,789,152 $381,842,823
2026-10-20 annual 2027-06-30 $-0.02 $-0.02 — $209,644,257 $208,126,014
2026-10-19 quarter 2030-09-30 $-0.02 $-0.02 — $87,947,240 $86,234,600
2026-10-19 annual 2029-06-30 $0.11 $0.11 — $738,032,500 $736,411,630
2026-10-19 annual 2027-06-30 $-0.02 $-0.02 — $210,106,714 $209,644,257
2026-10-19 quarter 2031-09-30 $0.02 $0.02 — $176,678,550 $169,086,826
2026-10-19 quarter 2031-03-30 $-0.01 $-0.01 — $103,155,367 $99,177,463
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms